Virtual assistant designed to support oncologists, urologists, nephrologists, pediatric oncologists, and primary care providers in the diagnosis, treatment, and follow-up of kidney cancer and Wilms tumor, based on the most recent scientific evidence (NCCN, ESMO, Children’s Oncology Group) and clinical guidelines current as of July 2025.
Content automatically generated by an artificial intelligence system.It may contain inaccuracies.